Processing

Please wait...

Settings

Settings

Goto Application

Offices all Languages Stemming false Single Family Member true

Save query

A private query is only visible to you when you are logged-in and can not be used in RSS feeds

Query Tree

Refine Options

Offices
All
Specify the language of your search keywords
Stemming reduces inflected words to their stem or root form.
For example the words fishing, fished,fish, and fisher are reduced to the root word,fish,
so a search for fisher returns all the different variations
Returns only one member of a family of patents

Full Query

IC:A61K36/00

Side-by-side view shortcuts

General
Go to Search input
CTRL + SHIFT +
Go to Results (selected record)
CTRL + SHIFT +
Go to Detail (selected tab)
CTRL + SHIFT +
Go to Next page
CTRL +
Go to Previous page
CTRL +
Results (First, do 'Go to Results')
Go to Next record / image
/
Go to Previous record / image
/
Scroll Up
Page Up
Scroll Down
Page Down
Scroll to Top
CTRL + Home
Scroll to Bottom
CTRL + End
Detail (First, do 'Go to Detail')
Go to Next tab
Go to Previous tab

Analysis

1.WO/2021/011002COMPOSITIONS AND METHODS FOR INDUCING DEFECATION
WO 21.01.2021
Int.Class A61K 36/81
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
36Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
18Magnoliophyta (angiosperms)
185Magnoliopsida (dicotyledons)
81Solanaceae (Potato family), e.g. tobacco, nightshade, tomato, belladonna, capsicum or jimsonweed
Appl.No PCT/US2019/042320 Applicant DIGNIFY THERAPEUTICS, LLC Inventor THOR, Karl, Bruce
Methods, pharmaceutical formulations, and kits are provided for using capsaicin to effectuate voluntary defecation in mammals who cannot defecate without external invasion of the bowel or those who defecate involuntarily (i.e., those having fecal incontinence). The pharmaceutical formulations and kits can also be useful for inducing defecation in mammals that do not have defecation dysfunction such as, for example, in a person who is unconscious and may defecate unconsciously or in a pet at a convenient location at a specific time. The methods and compositions provide patients with defecation dysfunction control over when and where they defecate.
2.WO/2021/007626ORAL MEDICATION FOR TREATING LIPOEDEMA
WO 21.01.2021
Int.Class A61K 38/04
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
38Medicinal preparations containing peptides
04Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
Appl.No PCT/BR2019/000026 Applicant BENITTI, Daniel Augusto Inventor BENITTI, Daniel Augusto
This is a product for use in the pharmaceutical sector. The present invention relates to a new and novel medication for treating lipoedema, which is a chronic hereditary fat distribution disorder characterized by an increase in subcutaneous adipose tissue (lipohypertrophy), by means of a formulation that has been shown to be effective in treating the disease, using various components: Citrus sinensis, Curcumin and Piperine, inter alia.
3.WO/2021/010791COMPOSITION FOR ALLEVIATING, PREVENTING, OR TREATING CARDIOVASCULAR DISORDERS, CONTAINING BIOCONVERTED SALVIA MILTIORRHIZA EXTRACT AND BIOCONVERTED RED GINSENG EXTRACT
WO 21.01.2021
Int.Class A61K 36/537
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
36Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
18Magnoliophyta (angiosperms)
185Magnoliopsida (dicotyledons)
53Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
537Salvia (sage)
Appl.No PCT/KR2020/009458 Applicant RE BIO, INC. Inventor PARK, Gunkook
The present invention relates to a composition for preventing or treating cardiovascular disorders, containing a bioconverted Salvia miltiorrhiza extract and a bioconverted red ginseng extract, and a bioconverted extract complex prepared by processing, with enzymes, the Salvia miltiorrhiza extract and the red ginseng extract and then reacting same with a Trichoderma reesei culture medium has the effects of increasing the activity of endothelial cells and inhibiting inflammation and, thus, can be effectively used to prevent or treat cardiovascular disorders.
4.WO/2021/010790ANTICANCER COMPOSITION COMPRISING SALVIA MILTIORRHIZA BIOCONVERSION EXTRACT AND RED GINSENG BIOCONVERSION EXTRACT
WO 21.01.2021
Int.Class A61K 36/537
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
36Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
18Magnoliophyta (angiosperms)
185Magnoliopsida (dicotyledons)
53Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
537Salvia (sage)
Appl.No PCT/KR2020/009457 Applicant RE BIO, INC. Inventor PARK, Gunkook
The present invention relates to an anticancer composition comprising a Salvia miltiorrhiza bioconversion extract and a red ginseng bioconversion extract. A bioconversion complex extract, which is prepared by subjecting the Salvia miltiorrhiza extract and the red ginseng extract to enzymatic treatment, followed by reaction with a Trichoderma reesei culture, exhibits a superb effect on the inhibition of proliferation of cancer cells, and thus the complex extract can be effectively used in the prevention or treatment of cancer.
5.WO/2021/010953TOPICAL SKINCARE COMPOSITIONS COMPRISING CENTELLA ASIATICA
WO 21.01.2021
Int.Class A61K 36/23
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
36Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
18Magnoliophyta (angiosperms)
185Magnoliopsida (dicotyledons)
23Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
Appl.No PCT/US2019/041760 Applicant THE PROCTER & GAMBLE COMPANY Inventor VILLALOBOS, Janette, Marie
The present disclosure relates to a topical skincare composition comprising a Centella asiatica extract in combination with a Vincetoxicum officinale extract and/or a Populas alba extract. The present disclosure further relates to methods of treating symptoms of itch, redness, flaking, dryness, and/or roughness of the skin, scalp, and/or mucous membrane using such topical skincare compositions.
6.WO/2021/008265ANTI-AGING SOFT CAPSULE FOR MENOPAUSAL WOMEN AND PREPARATION METHOD THEREFOR
WO 21.01.2021
Int.Class A61K 36/48
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
36Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
18Magnoliophyta (angiosperms)
185Magnoliopsida (dicotyledons)
48Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
Appl.No PCT/CN2020/094141 Applicant ZAOZHUANG UNIVERSITY Inventor WANG, Jinglong
An anti-aging soft capsule for menopausal women and a preparation method therefor. The soft capsule is composed of capsule contents and a capsule shell. The capsule contents are prepared from soy isoflavone extract powder, pomegranate seed oil, a Limonium bicolor extract, a suspending agent, and a wetting agent; the capsule shell is prepared from gelatin, a plasticizer, a coloring agent, and water; the coloring agent is composed of a white pigment and a milk chocolate brown pigment. The soft capsule also has the functions of resisting oxidation and relieving symptoms of menopause, and can supplement blood and qi for the female, so that the female are aglow with health and fresh complexion, the skin becomes smooth and elastic, and the comprehensive physique of the female is improved.
7.WO/2021/011548SKIN CARE COMPOSITIONS COMPRISING SYNERGISTIC BLEND OF SACRED LOTUS AND TEA PLANT OR SACRED LOTUS AND GERMAN CHAMOMILE AND COSMETIC APPLICATIONS THEREOF
WO 21.01.2021
Int.Class A61K 36/82
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
36Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
18Magnoliophyta (angiosperms)
185Magnoliopsida (dicotyledons)
82Theaceae (Tea family), e.g. camellia
Appl.No PCT/US2020/041953 Applicant ISP INVESTMENTS LLC Inventor KOGANOV, Michael
The present invention is related to a skin care composition comprising (1) a physiologically acceptable medium and (2) a synergistic composition consisting of: a blend of a Nelumbo nucifera (Sacred Lotus) serum traction and a Camellia sinensis (Tea) serum, fraction in a respective weight ratio of 75:25; or a blend of a Nelumbo nucifera (Sacred Lotus) serum fraction and a Chamomilla recutita (German chamomile) serum fraction in a respective weight ratio of 75:25. The invention also relates to a method for improving skin appearance associated with skin aging comprising applying compositions thereof.
8.WO/2021/009640THERAPEUTIC POTENTIAL OF CURCUMIN/CYCLODEXTRIN/CELLULOSE NANOCRYSTALS IN THE TREATMENT OF PERIPHERAL NEUROPATHIES
WO 21.01.2021
Int.Class A61K 9/00
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
9Medicinal preparations characterised by special physical form
Appl.No PCT/IB2020/056505 Applicant UNIVERSITE DE LIMOGES Inventor CAILLAUD, Martial
The invention relates to a complex comprising: nanocrystals of cellulose, at least one molecule of β-cyclodextrin, and at least one molecule of curcumin, for use in the treatment of all types of peripheral neuropathy. The invention also relates to a pharmaceutical composition comprising at least the complex and at least one pharmaceutically acceptable excipient. The invention further relates to the use of the complex or the pharmaceutical composition, particularly in the form of a hydrogel, subcutaneous implant, implantable pump, or implanted biofunctionalised nerve conduit, in order to improve compliance with the treatment, to allow prolonged release of the complex and to achieve better pharmacokinetics.
9.WO/2021/004922COMPOSITIONS AND METHODS USING TRIGONELLINE TO PRODUCE INTRACELLULAR NICOTINAMIDE ADENINE DINUCLEOTIDE (NAD+) FOR TREATING OR PREVENTING PHYSIOLOGICAL DISORDERS OR STATES
WO 14.01.2021
Int.Class A61K 9/00
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
9Medicinal preparations characterised by special physical form
Appl.No PCT/EP2020/068788 Applicant SOCIÉTÉ DES PRODUITS NESTLÉ S.A. Inventor FEIGE, Jerome
Compositions consist essentially of trigonelline or consist of trigonelline. The compositions can be used in food or beverage applications, pharmaceutical formulations, or as a dietary supplement. The compositions can be administered to a mammal to treat or prevent a mitochondria-related disease or a condition associated with altered mitochondrial function in an individual in need thereof or at risk thereof. The mitochondria-related disease or condition is selected from the group consisting of deleterious effects of aging, stress (e.g., oxidative stress), obesity, overweight, reduced metabolic rate, metabolic syndrome, diabetes mellitus, complications from diabetes, hyperlipidemia, neurodegenerative disease, cognitive disorder, stress-induced or stress-related cognitive dysfunction, mood disorder, anxiety disorder, age-related neuronal death or dysfunction, chronic kidney disease, kidney failure, trauma, infection, cancer, hearing loss, macular degeneration, myopathies and dystrophies, and combinations thereof.
10.WO/2021/004921COMPOSITIONS AND METHODS USING TRIGONELLINE TO PRODUCE INTRACELLULAR NAD+
WO 14.01.2021
Int.Class A23L 33/105
AHUMAN NECESSITIES
23FOODS OR FOODSTUFFS; THEIR TREATMENT, NOT COVERED BY OTHER CLASSES
LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D91; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
33Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
10using additives
105Plant extracts, their artificial duplicates or their derivatives
Appl.No PCT/EP2020/068786 Applicant SOCIÉTÉ DES PRODUITS NESTLÉ S.A. Inventor FEIGE, Jerome
Compositions consist essentially of trigonelline or consist of trigonelline. The compositions can be used in food or beverage applications, pharmaceutical formulations, or as a dietary supplement. The compositions can be administered to a mammal to promote the increase of intracellular levels of nicotinamide adenine dinucleotide ("NAD+") in cells and tissues for improving cell and tissue survival or overall cell and tissue health. Preferably, NAD + biosynthesis is increased in one or more cells of a mammal, for example one or more cells that are part of at least one body part selected from the group consisting of a liver, a kidney, a brain, and a skeletal muscle.